RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497
- PMID: 39335086
- PMCID: PMC11428622
- DOI: 10.3390/antibiotics13090814
RETRACTED: Teklemariam et al. Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics 2023, 12, 497
Abstract
The journal retracts the article, "Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa", cited above [...].
Retraction of
-
Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa.Antibiotics (Basel). 2023 Mar 2;12(3):497. doi: 10.3390/antibiotics12030497. Antibiotics (Basel). 2023. Retraction in: Antibiotics (Basel). 2024 Aug 28;13(9):814. doi: 10.3390/antibiotics13090814. PMID: 36978364 Free PMC article. Retracted.
References
-
- Teklemariam A.D., Al-Hindi R.R., Alharbi M.G., Alotibi I., Azhari S.A., Qadri I., Alamri T., Esmael A., Harakeh S. RETRACTED: Isolation and Characterization of a Novel Lytic Phage, vB_PseuP-SA22, and Its Efficacy against Carbapenem-Resistant Pseudomonas aeruginosa. Antibiotics. 2023;12:497. doi: 10.3390/antibiotics12030497. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
